Advertisement
U.S. markets close in 25 minutes
Advertisement

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
2.8950-0.1150 (-3.82%)
As of 03:35PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Performance Outlook
Previous Close3.0100
Open2.9900
Bid2.8900 x 2900
Ask2.9000 x 1000
Day's Range2.8900 - 2.9900
52 Week Range2.7650 - 5.1900
Volume286,460
Avg. Volume406,600
Market Cap241.546M
Beta (5Y Monthly)0.12
PE Ratio (TTM)N/A
EPS (TTM)-1.5700
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AVIR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Atea Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 11/07/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more